InsidersTradesSigma
Beijing Biostar Pharmaceuticals Co., Ltd. - B: management transactions · Hong Kong · HKEX
HKEX:beijing-biostar-pharmaceuticals-co-ltd-b-h-sharesHK·HKEXMcap 1.6Bn€Healthcare
Browse the full directors' dealings record of Beijing Biostar Pharmaceuticals Co., Ltd. - B, a listed issuer based in Hong Kong. Shares are quoted on HK HK, under the authority of HKEX. Operating in the Healthcare sector, Beijing Biostar Pharmaceuticals Co., Ltd. - B has logged 2 reports. Market capitalisation: €1.6bn. The latest transaction was filed on 8 May 2026 — Purchase. Among the most active insiders: Qiu Rongguo. All data is free.
2
Insider Decl.
0
Thresholds
·
2 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2024 · cache
4.41 €
Analyst consensus
Income statement
Revenue71.9 M€
Gross profit61.1 M€85% margin
Net income−143.8 M€-200.1% margin
Valuation
P/Book2.1x
Balance sheet & cash
Market cap1.61 Bn€
Total debt1.2 M€
Free Cash Flow−143.5 M€
Debt / Equity0%
Profitability & ownership
ROE-18.0%
ROA-10.3%
% insiders46.1%
% institutions14.2%
Last declaration on 8 May 2026
Declarations2 total
Executives●Purchase4HKEX
57,830,299 shares
ShareXHKG
HKEX:DA20260508E00311·
Ideal exit: 26 Dec 2026 (T+270)
2 of 2 declarations